Association between gene PPARG RS1801282 PRO12ALA and type 2 diabetes in Novosiborsk region and other populations
https://doi.org/10.29001/2073-8552-2014-29-2-75-78
Abstract
About the Authors
I. A. BondarRussian Federation
M. L. Filipenko
Russian Federation
O. Y. Shabelnikova
Russian Federation
E. A. Sokolova
Russian Federation
References
1. Кайдашев И.П., Расин А.М., Шлыкова О.А. и др. Частота Про-12Ала полиморфизма гена РРМг2 в украинской популяции и его возможная связь с развитием метаболического синдрома // Цитология и генетика. - 2007. - № 5. - С. 43-47.
2. Потапов В.А. Поиск генетических маркеров, определяющих предрасположенность к сахарному диабету 2-го типа: автореф. дис.. канд. биол. наук. - М., 2010. - 24 с.
3. Altshuler D., Hirschhorn J.N., Klannemark M. еt al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes // Nat. Genet. - 2000. -No. 26. - P. 76-80.
4. Deeb S.S., Fajas L., Nemoto M. et al. A Pro12Ala substitution in PPARg2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity // Nat. Genet. -1998. - No. 20. - P. 284-287.
5. Fu M., Chen H., Li X. et al. Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus // Chinese J. Med. Gen. - 2002. -Vol. 19(3). - P. 234-238.
6. Grundy S.M., Cleeman J.I., Merz C.N. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines // Circulation. - 2004. -Vol. 110(2). - P. 227-239.
7. Kao W.H., Coresh J., Shuldiner A.R. et al. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study // Diabetes. - 2003. - Vol. 52(6). - P. 1568-1572.
8. Malecki T.M., Fray J., Klupa T. The Pro12Ala polymorphism of РРМг2 gene and susceptibility to type 2 diabetes mellitus in a Polish population // Diabetes Res. Clin. Pract. - 2003. -Vol. 62(2). - P. 105-111.
9. Mori H., Ikegami H., Kawaguchi Y. et al. Pro12Ala substitution in PPAR gamma: is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes // Diabetes. - 2001. - Vol. 50. - P. 891-894.
10. Pinterova D., Cerna M., Kolostova K. еt al. The frequency of alleles of the Pro12Ala polymorphism in PPARgamma2 is different between healthy controls and patients with type 2 diabetes // Folia Biol. (Praha). - 2004. - No. 5. - P. 153-156.
11. Sanghera D.K., Blackett P.R. Type 2 Diabetes Genetics: Beyond GWAS // J. Diabetes Metab. - 2012. - Vol. 3(05). - P. 2-17.
12. Waters K.M., Stam D.O., Hassanein M.T. et al. Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups // PLoS Genet. - 2010. -Vol. 6, Issue 8. - e1001078.
13. Yen C.J., Beamer B.A., Negri C. et al. Molecular scanning of the human Peroxisome proliferator activated receptor g (hPPARg) gene in diabetic Caucasians: identification of a Pro12Ala PPARg2 missense mutation // Biochem. Biophys. Res. Commun. - 1997. - Vol. 241. - P. 270-274.
Review
For citations:
Bondar I.A., Filipenko M.L., Shabelnikova O.Y., Sokolova E.A. Association between gene PPARG RS1801282 PRO12ALA and type 2 diabetes in Novosiborsk region and other populations. Siberian Journal of Clinical and Experimental Medicine. 2014;29(2):75-78. (In Russ.) https://doi.org/10.29001/2073-8552-2014-29-2-75-78